Mad in America
OCTOBER 12, 2024
It seemed then that pharmaceutical companies had discovered scientific, targeted treatments for depression, free of side effects. In 2004, in response to Kim Witczak and other surviving families, the FDA began requiring SSRI drugmakers to add a Box Warning on the packaging of all SSRI antidepressants related to suicide risk.
Mad in America
MARCH 5, 2025
He started college in 2004, so this would have been 2005 or 2006. I dont know this for a fact, but Id bet a lot of money goes into The New York Times from pharmaceutical advertising. At the time, I didnt know much about it, but I knew it wasnt good. We were coming off the popularity of Ritalin, and now it was Adderall.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Mad in America
JANUARY 4, 2025
In our 2015 book Psychiatry Under the Influence , Lisa Cosgrove and I wrote about the STAR*D scandal in depth, as it served as an example of the institutional corruption in psychiatry due to pharmaceutical interests and psychiatrys own guild interests. The 12 STAR*D authors listed a collective total of 151 ties to pharmaceutical companies.
Mad in America
JANUARY 29, 2024
If one reads the ADM literature, it is quite apparent that the pharmaceutical industry—with the help of psychiatry—since day one has been involved in a cover up of the dangerousness of these drugs. of the drugs reviewed had two or fewer cases of violence, which is reassuring for most pharmaceuticals.
Mad in America
JANUARY 9, 2024
Academics even boast that EBM shackles the pharmaceutical industry. In 2004, the evidence that pretty well the entire pediatric antidepressant literature was fake, with GSK sued for fraud, caused Cochrane problems. Since 2004, they have been telling us to report adverse effects to the FDA and not to them. Just the opposite.
Mad in America
JULY 13, 2024
2004) and Diamond et al. Doctors are no longer the only gatekeepers of medical knowledge and although this opens people up to the nefarious influence of the pharmaceutical industry or quackery, it also creates opportunities for people to inform themselves and each other outside of the medical system. Ghaemi cites Sweeting et al.
Mad in America
JANUARY 25, 2025
The 2004 national South Africa Stress and Health study , the first large-scale research project of its kind in the country, found the lifetime prevalence of any DSM mental health diagnosis to be 30.3%. Where treatment is available, pharmaceutical interventions are often all thats on offer.
Expert insights. Personalized for you.
139 
Let's personalize your content